• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Two-year outcome after biodegradable polymer sirolimus- and biolimus-eluting coronary stents (from the randomised SORT OUT VII trial).

作者信息

Jensen Lisette Okkels, Maeng Michael, Raungaard Bent, Hansen Knud Nørregaard, Kahlert Johnny, Jensen Svend Eggert, Hansen Henrik Steen, Lassen Jens Flensted, Bøtker Hans Erik, Christiansen Evald Høj

机构信息

Department of Cardiology, Odense University Hospital, Odense, Denmark.

出版信息

EuroIntervention. 2018 Jan 20;13(13):1587-1590. doi: 10.4244/EIJ-D-17-00731.

DOI:10.4244/EIJ-D-17-00731
PMID:28870882
Abstract
摘要

相似文献

1
Two-year outcome after biodegradable polymer sirolimus- and biolimus-eluting coronary stents (from the randomised SORT OUT VII trial).生物可降解聚合物西罗莫司和生物雷帕霉素洗脱冠状动脉支架植入术后两年的结果（来自随机SORT OUT VII试验）
EuroIntervention. 2018 Jan 20;13(13):1587-1590. doi: 10.4244/EIJ-D-17-00731.
2
Randomized Comparison of a Biodegradable Polymer Ultrathin Strut Sirolimus-Eluting Stent With a Biodegradable Polymer Biolimus-Eluting Stent in Patients Treated With Percutaneous Coronary Intervention: The SORT OUT VII Trial.经皮冠状动脉介入治疗患者中可生物降解聚合物超薄支柱西罗莫司洗脱支架与可生物降解聚合物比伐卢定洗脱支架的随机对照比较：SORT OUT VII试验
Circ Cardiovasc Interv. 2016 Jul;9(7). doi: 10.1161/CIRCINTERVENTIONS.115.003610.
3
Comparison of Durable-Polymer Zotarolimus-Eluting and Biodegradable-Polymer Biolimus-Eluting Coronary Stents in Patients With Coronary Artery Disease: 3-Year Clinical Outcomes in the Randomized SORT OUT VI Trial.比较载有雷帕霉素的可降解聚合物涂层与载有紫杉醇的可降解聚合物涂层冠状动脉支架在冠状动脉疾病患者中的应用：随机 SORT OUT VI 试验 3 年的临床结果。
JACC Cardiovasc Interv. 2017 Feb 13;10(3):255-264. doi: 10.1016/j.jcin.2016.11.007. Epub 2017 Jan 18.
4
Final five-year outcomes after implantation of biodegradable polymer-coated biolimus-eluting stents versus durable polymer-coated sirolimus-eluting stents.生物可降解聚合物涂层雷帕霉素洗脱支架与永久性聚合物涂层西罗莫司洗脱支架植入后 5 年的最终结果。
EuroIntervention. 2017 Dec 20;13(11):1336-1344. doi: 10.4244/EIJ-D-17-00434.
5
Biodegradable Polymer Biolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents in Patients With Coronary Artery Disease: Final 5-Year Report From the COMPARE II Trial (Abluminal Biodegradable Polymer Biolimus-Eluting Stent Versus Durable Polymer Everolimus-Eluting Stent).生物可降解聚合物比伐卢定洗脱支架与耐久性聚合物依维莫司洗脱支架治疗冠状动脉疾病患者的比较：来自 COMPARE II 试验的最终 5 年报告（管腔生物可降解聚合物比伐卢定洗脱支架与耐久性聚合物依维莫司洗脱支架）。
JACC Cardiovasc Interv. 2017 Jun 26;10(12):1215-1221. doi: 10.1016/j.jcin.2017.02.029. Epub 2017 May 31.
6
Five-year outcomes from a trial of three limus-eluting stents with different polymer coatings in patients with coronary artery disease: final results from the ISAR-TEST 4 randomised trial.一项针对冠心病患者使用三种不同聚合物涂层雷帕霉素洗脱支架的试验的五年结果：ISAR-TEST 4随机试验的最终结果
EuroIntervention. 2016 Mar;11(12):1372-9. doi: 10.4244/EIJY14M11_02.
7
Improved safety and reduction in stent thrombosis associated with biodegradable polymer-based biolimus-eluting stents versus durable polymer-based sirolimus-eluting stents in patients with coronary artery disease: final 5-year report of the LEADERS (Limus Eluted From A Durable Versus ERodable Stent Coating) randomized, noninferiority trial.与含有不可降解聚合物的西罗莫司洗脱支架相比，含可生物降解聚合物的比伐卢定洗脱支架在冠状动脉疾病患者中具有更好的安全性和降低支架血栓形成的风险：LEADERS（雷帕霉素从不可降解到可降解涂层支架洗脱）随机、非劣效性试验的最终 5 年报告。
JACC Cardiovasc Interv. 2013 Aug;6(8):777-89. doi: 10.1016/j.jcin.2013.04.011.
8
Metallic Limus-Eluting Stents Abluminally Coated with Biodegradable Polymers: Angiographic and Clinical Comparison of a Novel Ultra-Thin Sirolimus Stent Versus Biolimus Stent in the DESTINY Randomized Trial.载有雷帕霉素的金属雷帕霉素洗脱支架经血管外涂层生物可降解聚合物：新型超薄西罗莫司支架与比马前列素支架在 DESTINY 随机试验中的血管造影和临床比较。
Cardiovasc Ther. 2015 Dec;33(6):367-71. doi: 10.1111/1755-5922.12159.
9
Five-year outcomes of patients with diabetes mellitus treated with a sirolimus-eluting or a biolimus-eluting stents with biodegradable polymer. From the SORT OUT VII trial.载有西罗莫司或依维莫司的可生物降解聚合物涂层支架治疗糖尿病患者的 5 年结果：来自 SORT OUT VII 试验。
Diab Vasc Dis Res. 2024 Sep-Oct;21(5):14791641241283939. doi: 10.1177/14791641241283939.
10
Impact of diabetes on clinical outcomes after revascularization with sirolimus-eluting and biolimus-eluting stents with biodegradable polymer from the SORT OUT VII trial.SORT OUT VII 试验中，载有可生物降解聚合物的西罗莫司洗脱和依维莫司洗脱支架血运重建后糖尿病对临床结局的影响。
Catheter Cardiovasc Interv. 2019 Mar 1;93(4):567-573. doi: 10.1002/ccd.27891. Epub 2018 Sep 23.

引用本文的文献

1
Drug-Eluting Stent Use in Percutaneous Coronary Interventions-A Narrative Review.药物洗脱支架在经皮冠状动脉介入治疗中的应用——一篇叙述性综述
J Clin Med. 2025 Jul 1;14(13):4643. doi: 10.3390/jcm14134643.
2
Everolimus-eluting versus biolimus-eluting stents with biodegradable polymers in unselected patients undergoing percutaneous coronary intervention: five-year results of the randomised, non-inferiority SORT OUT VIII trial.在接受经皮冠状动脉介入治疗的未选择患者中，依维莫司洗脱支架与含可生物降解聚合物的生物雷帕霉素洗脱支架对比：随机、非劣效性SORT OUT VIII试验的五年结果
EuroIntervention. 2025 Jun 2;21(11):e629-e638. doi: 10.4244/EIJ-D-24-00763.
3
Comparative effectiveness of ultrathin vs. standard strut drug-eluting stents: insights from a large-scale meta-analysis with extended follow-up.
超小径药物洗脱支架与标准支架的比较效果：一项具有延长随访的大规模荟萃分析的见解。
Eur J Med Res. 2024 Jul 27;29(1):388. doi: 10.1186/s40001-024-01949-7.
4
Outcome of percutaneous coronary intervention using ultrathin-strut biodegradable polymer sirolimus-eluting versus thin-strut durable polymer zotarolimus-eluting stents in patients with comorbid peripheral arterial disease: a post-hoc analysis from two randomized trials.合并外周动脉疾病患者使用超薄支撑可生物降解聚合物西罗莫司洗脱支架与薄支撑耐用聚合物佐他莫司洗脱支架进行经皮冠状动脉介入治疗的结果：两项随机试验的事后分析
Cardiovasc Diagn Ther. 2023 Aug 31;13(4):673-685. doi: 10.21037/cdt-22-584. Epub 2023 Jul 24.
5
Is There an Advantage of Ultrathin-Strut Drug-Eluting Stents over Second- and Third-Generation Drug-Eluting Stents?超薄支柱药物洗脱支架相对于第二代和第三代药物洗脱支架有优势吗？
J Pers Med. 2023 Apr 28;13(5):753. doi: 10.3390/jpm13050753.
6
Ultrathin Struts Drug-Eluting Stents: A State-of-the-Art Review.超薄支架药物洗脱支架：最新综述
J Pers Med. 2022 Aug 25;12(9):1378. doi: 10.3390/jpm12091378.
7
Polymer-free biolimus-coated stents versus ultrathin-strut biodegradable polymer sirolimus-eluting stents: two-year outcomes of the randomised SORT OUT IX trial.无聚合物涂层的依维莫司涂层支架与超小径可降解聚合物西罗莫司洗脱支架的比较：随机 SORT OUT IX 试验的 2 年结果。
EuroIntervention. 2022 Jun 3;18(2):e124-e131. doi: 10.4244/EIJ-D-21-00874.
8
CVIT expert consensus document on primary percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI) in 2018.2018年心血管介入治疗学会（CVIT）关于急性心肌梗死（AMI）的直接经皮冠状动脉介入治疗（PCI）专家共识文件。
Cardiovasc Interv Ther. 2018 Apr;33(2):178-203. doi: 10.1007/s12928-018-0516-y. Epub 2018 Mar 29.